Episealer® (knee) to be presented at the British knee congress

Episurf Medical (Nasdaq: EPIS B) today announces that the Episealer® Knee technology is presented at the UK Biological Knee Society’s Annual Meeting 2022 (Peckforton Castle, Cheshire, March 15-16),  as a part of the scientific program. The presentation is held by Mr Paul Jermin from Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust, Oswestry, United Kingdom, and focuses on surgical technology and clinical results from the use of the Episealer® Knee implant.

“As the orthopaedic community once again gathers for important physical meetings, we are pleased to see that the Episealer® is on the agenda. The UK market will grow in importance for us, and this is a great forum for our technology”, says Pål Ryfors, CEO, Episurf Medical.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: